Helix logo

Helix Funding & Investors

Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+™ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.

helix.com

Total Amount Raised: $403,000,000

Helix Funding Rounds

  • Series C

    $50,000,000

    Series C Investors

    Warburg Pincus
    Kleiner Perkins Caufield & Byers
    Temasek
    Mayo Clinic Ventures
    DFJ Growth
  • Grant

    $33,000,000

    Grant Investors

    National Institutes of Health (NIH)
  • Series B

    $200,000,000

    Series B Investors

    Sutter Hill Ventures
    Warburg Pincus
    Illumina
    Mayo Clinic
    Kleiner Perkins Caufield & Byers
    Temasek
    DFJ Growth
  • Series Unknown

    $20,000,000

    Series Unknown Investors

    Kleiner Perkins Caufield & Byers
    Casdin Capital
  • Series A

    $100,000,000

    Series A Investors

    Sutter Hill Ventures
    Warburg Pincus
    LaunchCapital
    Illumina
    Mayo Clinic
Funding info provided by Diffbot.